Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 4, 2008 - Issue 3
Submit an article Journal homepage
542
Views
42
CrossRef citations to date
0
Altmetric
Review

The hepatic safety profile of duloxetine: a review

Roger S McIntyre University of Toronto, Department of Psychiatry, Toronto, ON, Canada; University of Toronto, Department of Pharmacology, Toronto, ON, Canada; University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]; University of Toronto, Institute of Medical Science, Toronto, ON, Canada
,
Zilomi D Panjwani University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]
,
Ha T Nguyen University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]
,
Hanna O Woldeyohannes University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]
,
Mohammad Alsuwaidan University of Toronto, Department of Psychiatry, Toronto, ON, Canada; University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]
,
Joanna K Soczynska University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]; University of Toronto, Institute of Medical Science, Toronto, ON, Canada
,
Maria T Lourenco University of Toronto, Department of Psychiatry, Toronto, ON, Canada; University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]
,
Jakub Z Konarski University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]; University of Toronto, Institute of Medical Science, Toronto, ON, Canada
&
Sidney H Kennedy University of Toronto, Department of Psychiatry, Toronto, ON, Canada; University Health Network, Mood Disorders Psychopharmacology Unit, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada +1 416 603 5279; +1 416 603 5368; [email protected]; University of Toronto, Institute of Medical Science, Toronto, ON, Canada
 show all
Pages 281-285 | Published online: 26 Mar 2008

Bibliography

  • Arnold LM, Pritchett YL, D'Souza DN, et al. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials. J Womens Health (Larchmt) 2007;16:1145-56
  • Suri A, Reddy S, Gonzales C, et al. Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects. Int J Clin Pharmacol Ther 2005;43:78-84
  • McIntyre RS, Konarski JZ. Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms. Expert Opin Pharmacother 2005;6:707-13
  • Temple RJ, Himmel MH. Safety of newly approved drugs: implications for prescribing. JAMA 2002;287:2273-5
  • Bleibel W, Kim S, D'Silva K, Lemmer ER. Drug-induced liver injury: review article. Dig Dis Sci 2007;52:2463-71
  • DeSanty KP, Amabile CM. Antidepressant-induced liver injury. Ann Pharmacother 2007;41:1201-11
  • Spigset O, Hagg S, Bate A. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol 2003;18:157-61
  • Available from: www.clinicaltrials.gov. 2008. Ref Type: Conference Proceeding
  • Available from: www.fda.gov. 2008. Ref Type: Conference Proceeding
  • Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54
  • Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-5
  • Duh MS, Walker AM, Kronlund KH Jr. Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts. Pharmacoepidemiol Drug Saf 1999;8:275-83
  • Lewis JH. The rational use of potentially hepatotoxic medications in patients with underlying liver disease. Expert Opin Drug Saf 2002;1:159-72
  • Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-85
  • Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296:87-93
  • Russo MW, Watkins PB. Are patients with elevated liver tests at increased risk of drug-induced liver injury? Gastroenterology 2004;126:1477-80
  • Holt MP, Ju C. Mechanisms of drug-induced liver injury. AAPS J 2006;8:E48-54
  • McIntyre RS, Soczynska JK, Beyer JL, et al. Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr Opin Psychiatry 2007;20:406-16
  • Wohlreich MM, Perahia DG, Acharya N, et al. Duloxetine hepatic effects: 2006 review. 2008; presented at ECNP in Vienna, Austria October 2007.
  • McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv 2006;57:1140-4
  • Raskin J, Wang F, Pritchett YL, Goldstein DJ. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med 2006;7:373-85
  • Hanje AJ, Pell LJ, Votolato NA, et al. Case report: fulminant hepatic failure involving duloxetine hydrochloride. Clin Gastroenterol Hepatol 2006;4:912-7
  • Wernicke J, Pangallo B, Wang F, et al. Hepatic effects of Duloxetine-I: non-clinical and clinical trial data. 2008 In press
  • Strombom I, Wernicke JF, D'Souza DN, Acharya N. Hepatic effects of duloxetine – III: analysis of hepatic events using external data sources. 2008; In press
  • Wernicke J, Acharya N, Strombom I, et al. Hepatic effects of duloxetine – II: spontaneous reports and epidemiology of hep events. 2008; In press

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.